Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2007

01-09-2007 | Original Investigation

Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students

Authors: Sabine Wicker, Holger F. Rabenau, René Gottschalk, Hans Wilhelm Doerr, Regina Allwinn

Published in: Medical Microbiology and Immunology | Issue 3/2007

Login to get access

Abstract

In the course of clinical training medical students are in particular exposed to infectious diseases. Therefore, the present study was performed to investigate the immunity status of 223 medical students in their first clinical semester to job-related diseases. Specific serological antibody testing of hepatitis B-virus (HBV), hepatitis C-virus (HCV), human immunodeficiency virus (HIV), varicella zoster- (VZV), measles-, mumps-, rubella and polioviruses’ type 1, 2 and 3 were performed. The results yielded, that 69.5% of the students had an anti-HBs-level ≥10 IU/l and 54.7% ≥100 IU/l. Neither HCV infection nor HIV infection were found, but one student showed an active HBV infection. Virus specific immunity rates were found in 91.5% for measles, 80.3% for mumps, 90.1% for rubella and 96.9% for varicella. Furthermore the medical students demonstrated neutralizing antibodies to polioviruses: 95.1% (type 1), 96.9% (type 2) and 70% (type 3). 68.2% had antibodies (titer 1:≥10) against all three virus types. The partly significant gaps of immunity in the students need to be closed prior to the first contact with patients.
Literature
1.
go back to reference Allwinn R, Doerr HW (2003) Immunization against poliomyelitis—can it soon be dispensed with in Germany? Dtsch Med Wochenschr 128(33):1732PubMedCrossRef Allwinn R, Doerr HW (2003) Immunization against poliomyelitis—can it soon be dispensed with in Germany? Dtsch Med Wochenschr 128(33):1732PubMedCrossRef
2.
go back to reference Baer G, Bonhoeffer J, Schaad UB, Heininger U (2003) Protection against vaccine-preventable diseases in medical students. Paediatr Infect Dis J 22(4):373–374 Baer G, Bonhoeffer J, Schaad UB, Heininger U (2003) Protection against vaccine-preventable diseases in medical students. Paediatr Infect Dis J 22(4):373–374
3.
go back to reference Baer G, Bonhoeffer J, Schaad UB, Heininger U (2004) Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine 23:2016–2020CrossRef Baer G, Bonhoeffer J, Schaad UB, Heininger U (2004) Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine 23:2016–2020CrossRef
4.
go back to reference Buxbaum S, Doerr HW, Allwinn R (2001) Untersuchungen zur Immunitätslage der impfpräventablen Kinderkrankheiten Röteln, Masern, Mumps und Windpocken. Dtsch Med Wochenschr 126(46):1289–1293PubMedCrossRef Buxbaum S, Doerr HW, Allwinn R (2001) Untersuchungen zur Immunitätslage der impfpräventablen Kinderkrankheiten Röteln, Masern, Mumps und Windpocken. Dtsch Med Wochenschr 126(46):1289–1293PubMedCrossRef
5.
go back to reference Diedrich S, Claus H, Thierfelder W, Bellach BM, Schreier E (2000) German health survey 1997/98: immune status against poliomyelitis. Dtsch Med Wochenschr 125:584–588PubMed Diedrich S, Claus H, Thierfelder W, Bellach BM, Schreier E (2000) German health survey 1997/98: immune status against poliomyelitis. Dtsch Med Wochenschr 125:584–588PubMed
6.
go back to reference Diedrich S, Hermann C, Schreier E (2002) Immunity status against poliomyelitis in Germany: determination of cut-off values in international units. BMC Infect Dis 2:2PubMedCrossRef Diedrich S, Hermann C, Schreier E (2002) Immunity status against poliomyelitis in Germany: determination of cut-off values in international units. BMC Infect Dis 2:2PubMedCrossRef
7.
go back to reference Franck S, Allwinn R, Rabenau HF, Doerr HW (1999) Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German association against viral diseases (DVV). Zbl Bakt, Int J med Microbiol 289:475–481 Franck S, Allwinn R, Rabenau HF, Doerr HW (1999) Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German association against viral diseases (DVV). Zbl Bakt, Int J med Microbiol 289:475–481
8.
go back to reference Gottschalk R (2006) Ärzte und medizinisches Personal als Infektionsträger—Die Rolle des ÖGD—Berufsrechtliche Aspekte. Krankenhaushygiene Infektionsverhütung 23(1):21–24 Gottschalk R (2006) Ärzte und medizinisches Personal als Infektionsträger—Die Rolle des ÖGD—Berufsrechtliche Aspekte. Krankenhaushygiene Infektionsverhütung 23(1):21–24
9.
go back to reference Hamilton-West K (2006) Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus. Vaccine 24:5183–5191PubMedCrossRef Hamilton-West K (2006) Factors influencing MMR vaccination decisions following a mumps outbreak on a university campus. Vaccine 24:5183–5191PubMedCrossRef
10.
go back to reference Harling R, White JM, Ramsey ME, Macsween KF, van den Bosch C (2005) The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23:4070–4074PubMedCrossRef Harling R, White JM, Ramsey ME, Macsween KF, van den Bosch C (2005) The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23:4070–4074PubMedCrossRef
11.
go back to reference Matter GL (1999) Die Erhöhung der Immunitätsrate von Medizinstudentinnen und—studenten gegen Masern, Mumps und Röteln an der Universität Bern. Schweiz Med Wochenschr 129:499–507PubMed Matter GL (1999) Die Erhöhung der Immunitätsrate von Medizinstudentinnen und—studenten gegen Masern, Mumps und Röteln an der Universität Bern. Schweiz Med Wochenschr 129:499–507PubMed
12.
go back to reference Merkle E (2005) Gesundheit von Müttern und Kindern—Erfolge und Defizite. Lecture at the conference “Weltgesundheitstag 2005—Mutter und Kind—Gesundheit von Anfang an!”, April 06th, 2005, Berlin, Germany Merkle E (2005) Gesundheit von Müttern und Kindern—Erfolge und Defizite. Lecture at the conference “Weltgesundheitstag 2005—Mutter und Kind—Gesundheit von Anfang an!”, April 06th, 2005, Berlin, Germany
13.
go back to reference Rabenau HF, Weber B (1994) Evaluation of a new automated microneutralization assay for the quantitative detection of neutralizing antibodies against enteroviruses. Zbl Bakt, Int J med Microbiol 280:534–539 Rabenau HF, Weber B (1994) Evaluation of a new automated microneutralization assay for the quantitative detection of neutralizing antibodies against enteroviruses. Zbl Bakt, Int J med Microbiol 280:534–539
14.
go back to reference Radon K, Klewer J, Nowak D (2001) Befragung zum Impfstatus bei Medizinstudierenden in München. Gesundheitswesen 63:573–577PubMedCrossRef Radon K, Klewer J, Nowak D (2001) Befragung zum Impfstatus bei Medizinstudierenden in München. Gesundheitswesen 63:573–577PubMedCrossRef
15.
go back to reference Razum O, Queste A (2003) Schutzimpfung gegen Poliomyelitis—in Deutschland bald entbehrlich? Dtsch Med Wochenschr 128:882–886PubMedCrossRef Razum O, Queste A (2003) Schutzimpfung gegen Poliomyelitis—in Deutschland bald entbehrlich? Dtsch Med Wochenschr 128:882–886PubMedCrossRef
17.
go back to reference Tischer A, Gerike E (2000) Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 18:1382–1392PubMedCrossRef Tischer A, Gerike E (2000) Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 18:1382–1392PubMedCrossRef
18.
go back to reference Wallaschofski H, Drexler H, Schmid K (2005) Was wissen Medizinstudenten über ihren Impfstatus und wie ist ihr Impfschutz wirklich? Dtsch Med Wochenschr 130:1429–1433PubMedCrossRef Wallaschofski H, Drexler H, Schmid K (2005) Was wissen Medizinstudenten über ihren Impfstatus und wie ist ihr Impfschutz wirklich? Dtsch Med Wochenschr 130:1429–1433PubMedCrossRef
19.
go back to reference Weber B, Rabenau HF, Cinatl J, Maass G, Doerr HW (1994) Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay: a seroepidemiologic survey. Zbl Bakt, Int J med Microbiol 280:540–549 Weber B, Rabenau HF, Cinatl J, Maass G, Doerr HW (1994) Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay: a seroepidemiologic survey. Zbl Bakt, Int J med Microbiol 280:540–549
20.
go back to reference Wicker S (2006) Umgang mit infektiösen Beschäftigten—Aufgaben des Betriebsarztes. Krankenhaushygiene Infektionsverhütung 23(1):16–20 Wicker S (2006) Umgang mit infektiösen Beschäftigten—Aufgaben des Betriebsarztes. Krankenhaushygiene Infektionsverhütung 23(1):16–20
Metadata
Title
Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students
Authors
Sabine Wicker
Holger F. Rabenau
René Gottschalk
Hans Wilhelm Doerr
Regina Allwinn
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2007
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-007-0036-3

Other articles of this Issue 3/2007

Medical Microbiology and Immunology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.